0,845  0,004  Respiratory analeptic
0,820  0,013  Antiinflammatory
0,792  0,005  Analeptic
0,768  0,003  UGT1A4 substrate
0,744  0,005  Skin irritative effect
0,689  0,005  Antipsoriatic
0,676  0,004  Antiseptic
0,642  0,014  Antiasthmatic
0,610  0,007  Metabolic disease treatment
0,612  0,016  Toll-Like receptor 7 agonist
0,608  0,012  Immunosuppressant
0,607  0,016  Toll-Like receptor agonist
0,607  0,018  Rheumatoid arthritis treatment
0,616  0,046  Apoptosis agonist
0,569  0,003  Pneumotoxic
0,570  0,007  UGT1A1 substrate
0,578  0,018  Atherosclerosis treatment
0,565  0,009  UDP-glucuronosyltransferase substrate
0,570  0,017  CYP2C19 substrate
0,560  0,015  Cardioprotectant
0,551  0,017  CTGF expression inhibitor
0,548  0,016  Hepatic disorders treatment
0,557  0,026  CYP2C9 substrate
0,550  0,020  Bone diseases treatment
0,548  0,018  Spasmolytic
0,558  0,045  Autoimmune disorders treatment
0,514  0,004  Expectorant
0,528  0,017  Antifungal
0,542  0,039  Transcription factor NF kappa B inhibitor
0,512  0,009  Myocardial infarction treatment
0,521  0,019  Multiple sclerosis treatment
0,507  0,010  Psychostimulant
0,515  0,019  Antiosteoporotic
0,500  0,005  UGT2B7 substrate
0,511  0,018  Cardiovascular analeptic
0,511  0,022  Inflammatory Bowel disease treatment
0,503  0,022  Sensitization
0,482  0,003  UGT2B9 substrate
0,464  0,006  Systemic lupus erythematosus treatment
0,465  0,008  Non-steroidal antiinflammatory agent
0,487  0,035  Cholesterol antagonist
0,504  0,052  Antineoplastic (solid tumors)
0,478  0,044  Antileukemic
0,433  0,010  Contraceptive
0,475  0,053  TNF expression inhibitor
0,437  0,021  Tumour necrosis factor alpha release inhibitor
0,462  0,049  GST A substrate
0,416  0,003  Choleretic
0,416  0,009  Antiacne
0,416  0,011  Hair growth stimulant
0,409  0,007  Acaricide
0,450  0,049  Antipruritic, allergic
0,429  0,030  Chemoprotective
0,460  0,063  Antidiabetic
0,460  0,063  Cyclophilin D inhibitor
0,417  0,024  Nitric oxide antagonist
0,409  0,017  RNA-directed DNA polymerase inhibitor
0,433  0,054  Antiobesity
0,395  0,017  Antihelmintic
0,404  0,028  Proliferative diseases treatment
0,396  0,025  Antiparasitic
0,416  0,046  Antiallergic
0,397  0,028  Hypoglycemic
0,366  0,003  Mucolytic
0,390  0,028  Antineoplastic (lymphoma)
0,398  0,046  FMO1 substrate
0,401  0,049  Antithrombotic
0,387  0,038  Cytotoxic
0,368  0,020  Antiparkinsonian, rigidity relieving
0,391  0,047  Immunomodulator
0,376  0,037  NOS2 expression inhibitor
0,370  0,032  Chemopreventive
0,397  0,063  CYP3A4 substrate
0,361  0,027  Anticonvulsant
0,381  0,048  ICAM1 expression inhibitor
0,371  0,038  Antineoplastic (non-small cell lung cancer)
0,410  0,080  Analgesic
0,357  0,037  Antihypoxic
0,398  0,078  Antibacterial
0,354  0,036  Mutagenic
0,387  0,069  Antineoplastic (myeloid leukemia)
0,367  0,050  Antihypercholesterolemic
0,357  0,042  UGT2B4 substrate
0,337  0,023  Platelet adhesion inhibitor
0,321  0,008  Antifungal enhancer
0,312  0,009  Antitussive
0,346  0,052  Antiepileptic
0,323  0,030  Abortion inducer
0,324  0,034  GST M1-1 substrate
0,304  0,017  Sepsis treatment
0,291  0,007  ATPase inhibitor
0,291  0,009  Cachexia treatment
0,283  0,005  GABA C receptor antagonist
0,308  0,031  Sedative
0,277  0,008  Alcohol dehydrogenase substrate
0,286  0,018  CNS active muscle relaxant
0,289  0,022  Interferon gamma antagonist
0,307  0,041  5 Hydroxytryptamine uptake stimulant
0,317  0,051  Antipyretic
0,290  0,026  Antialcoholic
0,308  0,046  Angiogenesis stimulant
0,265  0,016  Cholesterol synthesis inhibitor
0,259  0,010  Farnesoid X receptor antagonist
0,297  0,049  Interleukin agonist
0,311  0,064  Antineoplastic (pancreatic cancer)
0,251  0,005  Actinic keratosis treatment
0,302  0,056  DNA damaging
0,321  0,076  Prostate cancer treatment
0,286  0,042  Antihypertriglyceridemic
0,256  0,013  GABA C receptor agonist
0,286  0,043  Gastrin inhibitor
0,259  0,017  Antihyperlipoproteinemic
0,293  0,051  Antiglaucomic
0,277  0,036  Hepatoprotectant
0,288  0,048  DNA synthesis inhibitor
0,282  0,043  Tyrosine 3 hydroxylase inhibitor
0,277  0,039  Antihypotensive
0,305  0,068  Antineoplastic (melanoma)
0,299  0,062  Teratogen
0,258  0,024  Prostate disorders treatment
0,264  0,030  Antipruritic, non-allergic
0,291  0,061  Transcription factor STAT inhibitor
0,260  0,032  Prostatic (benign) hyperplasia treatment
0,238  0,011  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,286  0,060  Transcription factor STAT3 inhibitor
0,252  0,027  Carcinogenic, group 3
0,255  0,032  Antieczematic atopic
0,235  0,013  Microtubule formation inhibitor
0,251  0,030  UGT1A3 substrate
0,254  0,034  Macular degeneration treatment
0,270  0,050  Transplant rejection treatment
0,261  0,041  VCAM1 expression inhibitor
0,248  0,031  Tumour necrosis factor antagonist
0,230  0,020  Cell wall synthesis inhibitor
0,237  0,028  Antiviral (Influenza A)
0,211  0,003  Andropause treatment
0,221  0,014  Antifungal (Cryptococcus)
0,305  0,100  Antineoplastic (non-Hodgkin's lymphoma)
0,231  0,026  Alpha-N-acetylglucosaminidase inhibitor
0,216  0,013  UGT2B1 substrate
0,291  0,088  Sodium/bile acid cotransporter inhibitor
0,214  0,012  Contraceptive female
0,211  0,011  Aldehyde dehydrogenase substrate
0,268  0,068  Embryotoxic
0,313  0,113  Antineoplastic (breast cancer)
0,262  0,062  Cytostatic
0,347  0,148  Caspase 9 stimulant
0,207  0,010  Hedgehog signaling inhibitor
0,239  0,043  CYP2B6 inhibitor
0,274  0,078  Lipoprotein disorders treatment
0,277  0,082  Antineoplastic (ovarian cancer)
0,220  0,024  UGT2B10 substrate
0,199  0,004  Antifungal (Aspergillus)
0,249  0,055  Antineoplastic enhancer
0,248  0,055  Carcinogenic
0,233  0,041  Eye irritation, high
0,245  0,053  Anesthetic general
0,290  0,101  Calcium channel activator
0,190  0,005  Paget's disease treatment
0,323  0,140  5 Hydroxytryptamine release inhibitor
0,205  0,023  Autism spectrum disorders treatment
0,208  0,026  DNA polymerase I inhibitor
0,219  0,037  Liver fibrosis treatment
0,186  0,005  5-Alpha-reductase inhibitor
0,270  0,091  NOS3 expression inhibitor
0,214  0,036  Melanin inhibitor
0,204  0,029  Arachidonic acid antagonist
0,193  0,019  Beta amyloid protein antagonist
0,187  0,015  DNA directed RNA polymerase inhibitor
0,190  0,020  MAP3K9 inhibitor
0,270  0,102  Antineoplastic (brain cancer)
0,206  0,039  Protein kinase stimulant
0,170  0,004  Narcotic antagonist
0,168  0,005  ATPase (Vacuolar H+) inhibitor
0,174  0,010  Ca2+-transporting ATPase inhibitor
0,171  0,009  Anabolic
0,200  0,039  Antirickettsial
0,184  0,024  Antineoplastic antibiotic
0,178  0,017  HDL-cholesterol increasing
0,177  0,017  TRPA1 agonist
0,279  0,120  Ulceration
0,200  0,043  UGT2B15 substrate
0,262  0,105  Interleukin 2 agonist
0,172  0,017  Androgen antagonist
0,217  0,064  Antiviral (Influenza)
0,261  0,109  AR expression inhibitor
0,236  0,085  Vascular (periferal) disease treatment
0,186  0,037  SULT1A3 substrate
0,185  0,038  M17 leucyl aminopeptidase inhibitor
0,237  0,091  UGT1A9 substrate
0,174  0,029  Ferrochelatase inhibitor
0,200  0,056  Lipocortins synthesis antagonist
0,186  0,045  Anesthetic
0,154  0,014  UGT2B11 substrate
0,145  0,006  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,146  0,008  Glycine receptor antagonist
0,217  0,080  UGT1A6 substrate
0,239  0,104  Antineoplastic (multiple myeloma)
0,243  0,110  CYP2D6 substrate
0,169  0,036  Adenylate cyclase stimulant
0,194  0,063  Sigma receptor agonist
0,188  0,058  Antipruritic
0,176  0,046  Raynaud's phenomenon treatment
0,218  0,090  Antineoplastic (glioma)
0,177  0,051  Hexokinase inhibitor
0,157  0,032  Vanilloid 1 agonist
0,144  0,020  GST T1-1 substrate
0,207  0,083  Antiulcerative
0,134  0,011  GABA aminotransferase inhibitor
0,200  0,077  Neurotrophic factor enhancer
0,155  0,034  Menstruation disorders treatment
0,137  0,018  Antidote, mercury
0,184  0,066  Muscle relaxant
0,139  0,021  ABCA1 expression enhancer
0,182  0,065  Succinate dehydrogenase inhibitor
0,129  0,013  Cannabinoid CB1 receptor agonist
0,177  0,063  Antimutagenic
0,125  0,011  Glycine receptor agonist
0,119  0,006  Liver X receptor agonist
0,177  0,063  Antihelmintic (Nematodes)
0,125  0,013  Na+ K+ transporting ATPase inhibitor
0,122  0,010  Anticholelithogenic
0,287  0,179  Alzheimer's disease treatment
0,218  0,110  Immunostimulant
0,117  0,010  Androgen agonist
0,154  0,047  Pregnane X receptor agonist
0,210  0,103  Antineoplastic (renal cancer)
0,111  0,007  Aconitate hydratase inhibitor
0,211  0,107  Antioxidant
0,128  0,024  Antibiotic
0,161  0,059  Antiparkinsonian, tremor relieving
0,197  0,096  Hypolipemic
0,140  0,041  SULT1A1 substrate
0,210  0,113  5 Hydroxytryptamine release stimulant
0,119  0,026  Ornithine decarboxylase inhibitor
0,153  0,060  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,136  0,043  Shock treatment
0,135  0,043  Antiviral (Influenza B)
0,302  0,211  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,162  0,071  Uterine stimulant
0,097  0,007  Postcoital contraceptive
0,154  0,063  Antiprotozoal (Coccidial)
0,094  0,004  Hypogonadism treatment
0,117  0,028  Glutamate receptor agonist
0,099  0,012  Estrogen receptor beta agonist
0,099  0,011  Glutamate (mGluR6) antagonist
0,217  0,132  CYP1A2 substrate
0,089  0,004  Pregnane X receptor antagonist
0,162  0,077  Muscular dystrophy treatment
0,157  0,073  Carcinogenic, group 1
0,141  0,057  Retinoprotector
0,219  0,137  FMO3 substrate
0,130  0,048  Constipation treatment
0,110  0,027  Contraceptive male
0,086  0,004  GABA uptake inhibitor
0,087  0,006  Retinoid X receptor agonist
0,090  0,010  Progesterone antagonist
0,194  0,114  Antineoplastic (liver cancer)
0,087  0,008  TRPM8 blocker
0,127  0,050  Excitatory amino acid transporter EAAC1 inhibitor
0,096  0,020  Vanilloid 4 agonist
0,112  0,037  Triose-phosphate isomerase inhibitor
0,112  0,039  Lanosterol 14 alpha demethylase inhibitor
0,203  0,132  Antidiabetic (type 2)
0,108  0,037  Antispirochetal
0,089  0,018  Cannabinoid CB2 receptor antagonist
0,124  0,053  Endometrios treatment
0,101  0,032  Vanilloid agonist
0,073  0,004  Tubulin agonist
0,183  0,114  Aldehyde oxidase inhibitor
0,106  0,038  ALK inhibitor
0,107  0,041  Antiviral (Rhinovirus)
0,085  0,019  SULT2A1 substrate
0,158  0,094  Toxic, respiratory center
0,076  0,012  Estrogen receptor alpha agonist
0,129  0,066  Cholinergic antagonist
0,178  0,116  Antiviral (HIV)
0,125  0,063  Sphingosine 1-phosphate receptor 4 antagonist
0,074  0,012  Anesthetic inhalation
0,109  0,047  Prolactin inhibitor
0,066  0,005  Kainate receptor agonist
0,150  0,090  Antiviral (Hepatitis C)
0,109  0,049  GST P1-1 substrate
0,067  0,008  Parathyroid hormone antagonist
0,067  0,009  Retinoid X alpha receptor agonist
0,141  0,084  Acetylcholine M1 receptor antagonist
0,061  0,005  Vanilloid 3 antagonist
0,135  0,079  Mannose-6-phosphate isomerase inhibitor
0,141  0,086  Antiviral (Herpes)
0,123  0,068  Acetylcholine antagonist
0,138  0,084  Antidote
0,064  0,010  Microtubule stabilization
0,105  0,051  Tourette's syndrome treatment
0,071  0,017  Dihydroorotate oxidase inhibitor
0,112  0,059  Carcinogenic, group 2B
0,078  0,026  Phosphatidylinositol 3-kinase delta inhibitor
0,072  0,020  Nicotinic receptor alpha7 subunit antagonist
0,081  0,031  Hyperparathyroidism treatment
0,153  0,104  Sleep disorders treatment
0,125  0,076  NADPH oxidase inhibitor
0,211  0,164  Vasodilator, peripheral
0,049  0,003  Vanilloid 2 agonist
0,054  0,009  Liver X receptor antagonist
0,084  0,039  Antidote, organophosphates
0,091  0,045  Acetylcholine nicotinic antagonist
0,072  0,029  Antimycoplasmal
0,102  0,059  UDP-glucose 4-epimerase inhibitor
0,116  0,073  Antifungal (Pneumocystis)
0,083  0,040  HIV-1 reverse transcriptase inhibitor
0,139  0,097  CF transmembrane conductance regulator agonist
0,090  0,048  mTOR complex 2 inhibitor
0,055  0,013  Glucocorticoid antagonist
0,082  0,040  Phosphofructokinase-1 inhibitor
0,068  0,027  Estrogen agonist
0,106  0,064  Antiprotozoal (Toxoplasma)
0,080  0,040  Cannabinoid receptor antagonist
0,085  0,044  Porphobilinogen synthase inhibitor
0,108  0,068  GABA receptor agonist
0,123  0,082  Cocaine dependence treatment
0,152  0,112  Antiviral (Hepatitis)
0,075  0,035  Gaucher disease treatment
0,051  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,063  0,023  Nicotinic alpha3beta2 receptor antagonist
0,115  0,076  Growth stimulant
0,129  0,091  Skeletal muscle relaxant
0,122  0,084  Bone formation stimulant
0,052  0,014  Farnesoid X receptor agonist
0,044  0,007  5-Alpha-reductase 1 inhibitor
0,130  0,093  Genotoxic
0,076  0,040  Neuronal nicotinic receptor antagonist
0,040  0,005  Hedgehog signaling activator
0,095  0,060  Bile acid receptor antagonist
0,099  0,064  GABA C receptor rho-1 antagonist
0,069  0,034  Antiviral (Parainfluenza)
0,099  0,065  Aminopeptidase B inhibitor
0,063  0,029  Ryanodine receptor antagonist
0,037  0,004  Progesterone receptor B antagonist
0,151  0,119  Antineoplastic (glioblastoma multiforme)
0,186  0,154  Flavin-containing monooxygenase substrate
0,072  0,040  Bcl2 antagonist
0,066  0,035  Biliverdin reductase inhibitor
0,115  0,083  Coagulant
0,068  0,037  Cannabinoid CB1 receptor antagonist
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,150  0,119  Phobic disorders treatment
0,068  0,037  Hypercalcemia treatment
0,046  0,016  Retinoid X receptor antagonist
0,044  0,013  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,061  0,030  Acetyl-CoA transferase 2 inhibitor
0,037  0,006  Nicotinic acid receptor 2 antagonist
0,079  0,049  Keratolytic
0,054  0,024  Glucose-6-phosphate isomerase inhibitor
0,070  0,041  Cannabinoid receptor agonist
0,088  0,059  NADH dehydrogenase inhibitor
0,095  0,066  Antifungal (Candida)
0,046  0,018  Retinoic acid alpha receptor agonist
0,135  0,108  Movement disorders treatment
0,041  0,014  Retinoid X alpha receptor antagonist
0,073  0,045  Prostaglandin-E synthase inhibitor
0,052  0,025  Cytokine production stimulant
0,059  0,032  Glucosylceramidase inhibitor
0,097  0,070  Antiviral (Poxvirus)
0,173  0,146  Nitric-oxide synthase stimulant
0,096  0,070  Gastric antisecretory
0,083  0,058  GABA A receptor agonist
0,075  0,050  Glutamate dehydrogenase inhibitor
0,054  0,029  Potassium channel (Inward rectifier) blocker
0,074  0,049  Aminopeptidase I inhibitor
0,061  0,036  Argininosuccinate synthase inhibitor
0,086  0,062  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,064  0,040  Carbamoyl phosphate synthetase inhibitor
0,214  0,190  GABA C receptor rho-3 antagonist
0,044  0,021  Membrane dipeptidase inhibitor
0,095  0,072  Glutathione S-transferase substrate
0,031  0,008  Prostaglandin F2 alpha agonist
0,035  0,012  Liver X receptor alpha antagonist
0,088  0,065  Restless leg syndrome treatment
0,074  0,051  CDC25A inhibitor
0,104  0,081  Photosensitizer
0,099  0,077  DOPA decarboxylase inhibitor
0,180  0,159  Neuropeptide Y2 antagonist
0,035  0,014  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,037  0,016  ATP citrate lysase inhibitor
0,112  0,091  Antismoking
0,104  0,084  Alkylator
0,055  0,035  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,024  0,004  Telomerase stimulant
0,187  0,168  Hypoxia-inducible factor 1 alpha inhibitor
0,101  0,082  Anesthetic local
0,023  0,005  Vitamin D receptor agonist
0,090  0,072  Creatine kinase inhibitor
0,035  0,017  Glutamate (mGluR3) agonist
0,141  0,124  LDLR expression enhancer
0,024  0,008  Retinoid X beta receptor antagonist
0,126  0,109  Sphingosine 1-phosphate receptor 5 antagonist
0,118  0,102  Peroxidase inhibitor
0,033  0,017  Liver X receptor beta antagonist
0,034  0,018  Cholesterol ester transfer protein antagonist
0,060  0,044  Transcription factor AP-1 inhibitor
0,044  0,028  Guanylate cyclase inhibitor
0,025  0,010  Vitamin D receptor antagonist
0,053  0,038  Alpha-mannosidase inhibitor
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,093  0,079  Adenylate kinase inhibitor
0,072  0,058  Analgesic, opioid
0,176  0,162  Anxiolytic
0,035  0,022  Adenosine uptake inhibitor
0,235  0,222  Calcium channel L-type activator
0,025  0,012  GRP78 expression inhibitor
0,080  0,067  Estrogen-related receptor beta agonist
0,026  0,014  Sodium/glucose cotransporter 1 inhibitor
0,094  0,082  Antiinfertility, female
0,056  0,046  Lipocortins synthesis agonist
0,037  0,028  Glutamate (mGluR8) agonist
0,054  0,045  Leukotriene C antagonist
0,100  0,091  Acetylcholine muscarinic antagonist
0,052  0,043  Alcohol oxidase inhibitor
0,098  0,090  Proteasome inhibitor
0,022  0,014  GABA transporter inhibitor
0,053  0,046  Aromatase inhibitor
0,018  0,011  CXC chemokine 5 receptor antagonist
0,152  0,145  Antiamyloidogenic
0,079  0,072  Transcription factor NF kappa B stimulant
0,114  0,108  Psychosexual dysfunction treatment
0,076  0,070  Inducible nitric-oxide synthase inhibitor
0,203  0,198  Histamine release inhibitor
0,069  0,064  Nicotinic alpha4beta2 receptor antagonist
0,083  0,078  Obsessive-compulsive disorder treatment
0,163  0,160  5 Hydroxytryptamine 3E antagonist
0,015  0,012  GABA transporter 1 inhibitor
0,010  0,006  Progesterone receptor A antagonist
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,118  0,115  Insulin secretagoues
0,078  0,075  T cell inhibitor
0,020  0,018  Glutamate (mGluR1a) agonist
0,156  0,154  VEGF expression inhibitor
0,016  0,014  Nicotinic acid receptor 1 antagonist
0,034  0,033  Glutamate (mGluR group II) antagonist
0,024  0,022  Sodium/glucose cotransporter inhibitor
0,028  0,026  Prostaglandin agonist
0,023  0,022  Glutamate (mGluR1) agonist
0,020  0,019  Excitatory amino acid transporter 3 inhibitor

